TECH-E: Evaluation of MoodRing on Improving the Quality of Depression Management in Adolescents

Sponsor
Ana Radovic (Other)
Overall Status
Recruiting
CT.gov ID
NCT05376358
Collaborator
NuRelm, Inc. (Industry), National Institute of Mental Health (NIMH) (NIH), University of Virginia (Other)
450
1
2
23.6
19

Study Details

Study Description

Brief Summary

The MoodRing intervention is a mobile application for adolescents, parents, and an accompanying web-based clinician portal which enables adolescents to monitor their mood through the use of passively collected smartphone data. This randomized controlled trial will evaluate whether MoodRing as compared to usual care improves the quality of depression management.

Condition or Disease Intervention/Treatment Phase
  • Device: MoodRing App
  • Other: Usual Care
N/A

Detailed Description

This is a randomized controlled trial to evaluate the efficacy of MoodRing as compared to usual care for adolescents who have a prior diagnosis of depression. Adolescents with depressive symptoms, their parents, and their mental healthcare providers (if interested) will participate in a 6 month study. Adolescents age 12-18 and their parent will be consented for the study and be sent an online survey to obtain baseline measures. Those who complete the baseline measures will then be randomized to receive the MoodRing intervention or treatment as usual. Adolescents and parents will be asked to complete data collection at 3 months and 6 month time points post-randomization by online survey. Additionally, data will be collected for 3 and 6 month timepoints via the adolescent's electronic health record data. At 6 months, online surveys will be sent and an invitation to interview for patients' mental healthcare providers who consent to participate in the study.

Adolescent-parent dyads will be randomized at a 1:1 ratio (using randomized block sizes) to either 1) MoodRing or 2) usual care. 100 adolescent-parent dyads (200 total individuals) will be randomized to MoodRing and 100 adolescent-parent dyads (200 total individuals) will be randomized to usual care. We expect 50 clinicians will participate. In both arms, passively collected data will be obtained from adolescent smartphones as well as weekly mood surveys and monthly sleep surveys. In the 1) MoodRing arm adolescents will download the MoodRing-adolescent app, parents will download the MoodRing-parent app, and healthcare providers if interested will have access to a clinician dashboard. The randomization tables will be generated by the study statistician.

The investigators hypothesize that adolescents who receive MoodRing as compared to usual care will have:

H1: An improved quality of depression management with regards to:
  • frequency of symptom reassessment measured by adolescent attendance at a healthcare provider visit for depression symptom reassessment within 3 months (yes/no; and number of visits) (primary outcome)

  • medication adherence measured by out of adolescents who are taking an antidepressant,

  • receiving at least 60 consecutive days (secondary outcome)

  • therapy adherence measured by out of adolescents who are referred for psychotherapy,

  • who receive at least 3 sessions within 3 months (secondary outcome)

EH2: The investigators will also explore whether MoodRing as compared to usual care will result in less healthcare utilization, decreased depression symptoms, improved sleep quality, and increased application of self-management activities through increased self-efficacy, utilization of self-management skills and knowledge and social support.

H3: The investigators anticipate healthcare providers, adolescents, and parents will report satisfaction with use of MoodRing.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
450 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This study will use a parallel study design, where participants are randomized into two intervention groups (Usual Care or MoodRing) and will receive interventions in parallel.This study will use a parallel study design, where participants are randomized into two intervention groups (Usual Care or MoodRing) and will receive interventions in parallel.
Masking:
Single (Outcomes Assessor)
Masking Description:
Outcomes assessors will be masked to the intervention condition at follow-up assessment time points.
Primary Purpose:
Health Services Research
Official Title:
Technology and Emotion Study "TECH-E": Randomized Controlled Trial of MoodRing Compared to Usual Care: Mobile Monitoring of Adolescent Depression Phase II
Actual Study Start Date :
May 12, 2022
Anticipated Primary Completion Date :
Mar 10, 2024
Anticipated Study Completion Date :
Apr 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Usual Care

Participants in this arm will receive no intervention and access treatment as usual per their mental health services provider. A mobile application (AWARE) which is not interactive and is only for purposes of data collection will be downloaded on the adolescents' smartphone.

Other: Usual Care
Adolescents and parents in the usual care arm will receive instructions to download the AWARE app. This app will only track data and will not be interactive. Otherwise they will receive care as per routine by their healthcare provider team.

Experimental: MoodRing

Adolescent participants in this arm will download two mobile applications - a data collection non-interactive app to collect passive sensing data (AWARE) and the MoodRing (MR) mobile application with which they can visualize their data about their mood, sleep, activity, enter their own mood score, and access psychoeducational resources including links to a research-based website, SOVA. Their parents will download a parent MoodRing application which provides them with parenting resources and articles and a weekly report of their adolescents' mood as predicted by passive sensing. Clinical providers will receive access to a web portal where they can view their adolescent patients' data who are enrolled in the study.

Device: MoodRing App
Adolescents and parents in the MR arm will receive instructions to download the MR app and AWARE app, customize the app, utilize an app-based self-guided onboarding, and review questions with the research team. The MR app provides the adolescent and their parent a notification to view a weekly report predicting their mood score (i.e. depression severity level similar to the Patient health questionnaire-9). The MR app will provide a library of coping strategies for adolescents and opportunities to self-track their mood. Clinicians in the MR Arm will get access to a MR portal online. They will be able to view patients they are a provider for. The clinician will receive in-person and/or video-based training to use the portal.

Outcome Measures

Primary Outcome Measures

  1. Quality of Depression Management: Depression Symptom Reassessment [3 months]

    Attendance at a healthcare provider visit for depression symptom reassessment within 3 months (yes/no) measured by adolescent, parent self-report and electronic health record review (yes if any are yes, no if all are no). The metric reported will be percentage of individuals per study arm with a 'yes' result.

  2. Quality of Depression Management: Medication Adherence [3 months]

    Out of adolescents who are taking an antidepressant, receipt of at least 60 consecutive days (yes/no) measured by adolescent, parent self-report and electronic health record review (yes if any are yes, no if all are no). The metric reported will be percentage of individuals per study arm with a 'yes' result.

  3. Quality of Depression Management: Therapy Adherence [3 months]

    Out of adolescents who are referred for psychotherapy, receipt of at least 3 sessions within 3 months (yes/no) measured by adolescent, parent self-report and electronic health record review (yes if any are yes, no if all are no). The metric reported will be percentage of individuals per study arm with a 'yes' result.

Secondary Outcome Measures

  1. Quality of Depression Management: Depression Symptom Reassessment change from baseline [6 months]

    Attendance at a healthcare provider visit for depression symptom reassessment within the past 3 months (yes/no) measured by adolescent, parent self-report and electronic health record review (yes if any are yes, no if all are no). The metric reported will be percentage of individuals per study arm with a 'yes' result.

  2. Quality of Depression Management: Medication Adherence [6 months]

    Out of adolescents who are taking an antidepressant, receipt of at least 60 consecutive days (yes/no) within the past 3 months, measured by adolescent, parent self-report and electronic health record review (yes if any are yes, no if all are no). The metric reported will be percentage of individuals per study arm with a 'yes' result.

  3. Quality of Depression Management: Therapy Adherence [6 months]

    Out of adolescents who are referred for psychotherapy, receipt of at least 3 sessions within the past 3 months (yes/no) measured by adolescent, parent self-report and electronic health record review (yes if any are yes, no if all are no). The metric reported will be percentage of individuals per study arm with a 'yes' result.

  4. Healthcare Utilization for acute care or primary care (for non mental-health reason) [3 month]

    Number of visits for (combined total between adolescent self-report, parent self-report, and electronic health-record review): urgent care; emergency room; inpatient hospitalization; acute primary care provider visit for non-mental health related concern; medical or surgical subspecialist visit

  5. Healthcare Utilization for acute care or primary care (for non mental-health reason) [6 month]

    Number of visits for (combined total between adolescent self-report, parent self-report, and electronic health-record review): urgent care; emergency room; inpatient hospitalization; acute primary care provider visit for non-mental health related concern; medical or surgical subspecialist visit

  6. Change from Baseline in Depression Severity at 3 months [From baseline to 3 months]

    Adolescents will be asked the PHQ-9 Patient Health Questionnaire-9 measures depression severity with a score ranging from 0 to 27, a higher score indicating greater severity.

  7. Change from Baseline in Depression Severity at 6 months [From baseline to 6 months]

    Adolescents will be asked the PHQ-9 Patient Health Questionnaire-9 measures depression severity with a score ranging from 0 to 27, a higher score indicating greater severity.

  8. Change from Baseline in Self-management behavior at 3 months [From baseline to 3 months]

    Adolescents will be asked Question 11 of Partners in Health Scale; and the average amount of time (Daily, More than once a week, Once a week, Once a month, Once a semester, Once a year, Less than once a year, Never) spent in potentially useful self-management activities: (1) created to-do lists to help me focus; (2) found strategies to create pleasurable distractions; (3) engaged in some physical activity (cycling, walking, etc.); (4) set realistic short-term goals; (5) made sure I had a good day/night routine with got enough sleep; (6) ensured enough rest to avoid getting exhausted; (7) left the house regularly; (8) ate healthy

  9. Change from Baseline in Self-management behavior at 6 months [From baseline to 6 months]

    Adolescents will be asked Question 11 of Partners in Health Scale; and the average amount of time (Daily, More than once a week, Once a week, Once a month, Once a semester, Once a year, Less than once a year, Never) spent in potentially useful self-management activities: (1) created to-do lists to help me focus; (2) found strategies to create pleasurable distractions; (3) engaged in some physical activity (cycling, walking, etc.); (4) set realistic short-term goals; (5) made sure I had a good day/night routine with got enough sleep; (6) ensured enough rest to avoid getting exhausted; (7) left the house regularly; (8) ate healthy

  10. Change from Baseline in Self-Efficacy at 3 months [From baseline to 3 months]

    Adolescents will be asked the Mental Health Self-efficacy Scale (MHSES) The Mental Health Self-efficacy Scale (Clarke, 2014) measures one's belief in one's capability to perform mental health self-care behaviors. The score ranges from 6 to 60, with higher scores indicating higher confidence in mental health selfcare.

  11. Change from Baseline in Self-Efficacy at 6 months [From baseline to 6 months]

    Adolescents will be asked the Mental Health Self-efficacy Scale (MHSES) The Mental Health Self-efficacy Scale (Clarke, 2014) measures one's belief in one's capability to perform mental health self-care behaviors. The score ranges from 6 to 60, with higher scores indicating higher confidence in mental health selfcare.

  12. Change from Baseline in Self-management knowledge and skills at 3 months [From baseline to 3 months]

    Adolescents will be asked the Partners in Health Scale The Partners in Health Scale (Battersby, 2003) assesses self-management with respect to a chronic condition, with regard to active involvement of a patient in managing their condition. Total scores range from 0 to 88 with higher scores indicating worse self-management.

  13. Change from Baseline in Self-management knowledge and skills at 6 months [From baseline to 6 months]

    Adolescents will be asked the Partners in Health Scale The Partners in Health Scale (Battersby, 2003) assesses self-management with respect to a chronic condition, with regard to active involvement of a patient in managing their condition. Total scores range from 0 to 88 with higher scores indicating worse self-management.

  14. Change from Baseline in Social Support at 3 months [From baseline to 3 months]

    Adolescents will be asked the Medical Outcomes Study Social Support Survey The Medical Outcome Study Social Support Scale (Sherbourne, 1991) measures types of social support. This subscale ranges from 0-100, with higher levels associated with greater support.

  15. Change from Baseline in Social Support at 6 months [From baseline to 6 months]

    Adolescents will be asked the Medical Outcomes Study Social Support Survey The Medical Outcome Study Social Support Scale (Sherbourne, 1991) measures types of social support. This subscale ranges from 0-100, with higher levels associated with greater support.

  16. Change from Baseline in Sleep-Related Impairment at 3 months [From baseline to 3 months]

    Adolescents will respond to the PROMIS Pediatric Sleep-Related Impairment scale. This scale has four questions with response options of never, almost never, sometimes, almost always, and always, ranges from 4 to 19 with higher scores indicating higher levels of sleep-related impairment.

  17. Change from Baseline in Sleep-Related Impairment at 6 months [From baseline to 6 months]

    Adolescents will respond to the PROMIS Pediatric Sleep-Related Impairment scale. This scale has four questions with response options of never, almost never, sometimes, almost always, and always, ranges from 4 to 19 with higher scores indicating higher levels of sleep-related impairment.

  18. Ongoing Change in Sleep-Related Impairment [monthly up to 6 months]

    Adolescents will respond to the PROMIS Pediatric Sleep-Related Impairment scale. This scale has four questions with response options of never, almost never, sometimes, almost always, and always, ranges from 4 to 19 with higher scores indicating higher levels of sleep-related impairment.

  19. Change from Baseline in Sleep Disturbance at 3 months [From baseline to 3 months]

    Adolescents will respond to the PROMIS Pediatric Sleep Disturbance scale. This scale has four questions, the second (sleeping through the night) being reverse-scored, with response options of never, almost never, sometimes, almost always, and always, ranges from 4 to 20 with higher scores indicating higher levels of sleep disturbance.

  20. Change from Baseline in Sleep Disturbance at 6 months [From baseline to 6 months]

    Adolescents will respond to the PROMIS Pediatric Sleep Disturbance scale. This scale has four questions, the second (sleeping through the night) being reverse-scored, with response options of never, almost never, sometimes, almost always, and always, ranges from 4 to 20 with higher scores indicating higher levels of sleep disturbance.

  21. Ongoing Change in Sleep Disturbance [monthly up to 6 months]

    Adolescents will respond to the PROMIS Pediatric Sleep Disturbance scale. This scale has four questions, the second (sleeping through the night) being reverse-scored, with response options of never, almost never, sometimes, almost always, and always, ranges from 4 to 20 with higher scores indicating higher levels of sleep disturbance.

  22. Change from Baseline in Sleep Habits at 3 months [From baseline to 3 months]

    Adolescents will respond to the School Based Sleep Habits Survey-Child Form which asks 43 questions about weekday and weeknight sleep patterns, sleep awakenings, and sleep time preferences.

  23. Change from Baseline in Sleep Habits at 6 months [From baseline to 6 months]

    Adolescents will respond to the School Based Sleep Habits Survey-Child Form which asks 43 questions about weekday and weeknight sleep patterns, sleep awakenings, and sleep time preferences.

  24. Ongoing Change in Sleep Habits [monthly up to 6 months]

    Adolescents will respond to the School Based Sleep Habits Survey-Child Form which asks 43 questions about weekday and weeknight sleep patterns, sleep awakenings, and sleep time preferences.

  25. Change from Baseline in Perceived Severity at 3 months [From baseline to 3 months]

    Rating scale of General Mental Health A rating scale of General Mental Health (Cadigan, 2018) will be used with two questions each ranging from 1 to 5 with regard to a self-rating of general mental health. Adolescents will be asked this and parents about their perception of their adolescent's mental health.

  26. Change from Baseline in Perceived Severity at 6 months [From baseline to 6 months]

    Rating scale of General Mental Health A rating scale of General Mental Health (Cadigan, 2018) will be used with two questions each ranging from 1 to 5 with regard to a self-rating of general mental health. Adolescents will be asked this and parents about their perception of their adolescent's mental health.

  27. Change from Baseline in Perceived Need for Service Use at 3 months [From baseline to 3 months]

    The General-practice Users Perceived-need Inventory (GUPI) The General-Practice Users Perceived-Need Inventory (McNab, 2004) will be used to measure perceived need for treatment. There is no scoring. Adolescents will be asked this and parents about their perception of their adolescent's need for mental health services. The response will be evaluated by the total number of individuals who agree that they would like to or are already getting help with a) medication and b) counseling as comapred to those who respond they do not need this kind of help.

  28. Change from Baseline in Perceived Need for Service Use at 6 months [From baseline to 6 months]

    The General-practice Users Perceived-need Inventory (GUPI) The General-Practice Users Perceived-Need Inventory (McNab, 2004) will be used to measure perceived need for treatment. There is no scoring. Adolescents will be asked this and parents about their perception of their adolescent's need for mental health services. The response will be evaluated by the total number of individuals who agree that they would like to or are already getting help with a) medication and b) counseling as comapred to those who respond they do not need this kind of help.

Other Outcome Measures

  1. Acceptability of MoodRing: Heathcare Provider Acceptability [at 6 months]

    System Usability Questionnaire (Bangor, 2008) asks 11 questions about the usability of a technological intervention. SUS scores range from 0-100. Higher scores indicate better usability.

  2. Acceptability of MoodRing as a clinical tool: Heathcare Provider Acceptability [at 6 months]

    Acceptability of Intervention Measure (AIM) (Weiner, 2017) asks 4 questions on a 1-5 Likert scale with completely disagree to completely agree with regards to acceptability of an intervention and 3 questions were added including with regards to efficiency, help taking care of patients, patient benefit from the intervention. Higher scores indicate higher acceptability. Also an open-ended question will be asked about feedback using MoodRing.

  3. Acceptability of MoodRing: Adolescent/Parent Acceptability [at 6 months]

    System Usability Questionnaire (Bangor, 2008) asks 11 questions about the usability of a technological intervention. SUS scores 0-100. Higher scores indicate better usability. Adolescents and Parents - only those randomized to the MoodRing arm - will be asked these questions.

  4. Acceptability of MoodRing as a self-management tool: Adolescent/Parent Acceptability [at 6 months]

    Acceptability of Intervention Measure (AIM) (Weiner, 2017) asks 4 questions on a 1-5 Likert scale with completely disagree to completely agree with regards to acceptability of an intervention. Additional questions will be asked about perceived benefit, taking care of mental health, and confidence in mental health management. Higher scores indicate higher acceptability. Also an open-ended question will be asked about feedback using MoodRing. Adolescents and Parents - only those randomized to the MoodRing arm - will be asked these questions.

  5. Ongoing Assessment of Depression Severity [Weekly up to 6 months]

    Adolescents will be asked the PHQ-8. Patient Health Questionnaire-8 measures depression severity with a score ranging from 0 to 24, a higher score indicating greater severity.

  6. Change from Baseline in Anxiety severity at 3 months [From baseline to 3 months]

    Adolescents will be asked the GAD-7 Generalized Anxiety Disorders 7-item Questionnaire measures extent of anxiety symptoms. The total score ranges from 0 to 21 with a higher score indicating greater severity.

  7. Change from Baseline in Anxiety severity at 6 months [From baseline to 6 months]

    Adolescents will be asked the GAD-7 Generalized Anxiety Disorders 7-item Questionnaire measures extent of anxiety symptoms. The total score ranges from 0 to 21 with a higher score indicating greater severity.

  8. Change from Baseline in Parent-Teen Communication Quality at 3 months [From baseline to 3 months]

    M-PACS (The Parent-Adolescent Communication Scale (Olson, 1985) modified for mental health) asks 20 questions with regards to communication between parents and adolescents, with responses 1-5 from strongly disagree to strongly agree. Some items are reverse scored with a higher scale score indicating better communication. Both adolescents and parents will be asked these questions.

  9. Change from Baseline in Parent-Teen Communication Quality at 6 months [From baseline to 6 months]

    M-PACS (The Parent-Adolescent Communication Scale (Olson, 1985) modified for mental health) asks 20 questions with regards to communication between parents and adolescents, with responses 1-5 from strongly disagree to strongly agree. Some items are reverse scored with a higher scale score indicating better communication. Both adolescents and parents will be asked these questions.

  10. Change from Baseline in Parent-Teen Relationship Quality at 3 months [From baseline to 3 months]

    The CPCS (Child Parent Connectedness Scale) asks 5 questions from a scale of 1-5 from strongly disagree to strongly agree with regards to connectedness and relationship satisfaction with each other. A higher score indicates higher child-parent connectedness. Both adolescents and parents will be asked these questions.

  11. Change from Baseline in Parent-Teen Relationship Quality at 6 months [From baseline to 6 months]

    The CPCS (Child Parent Connectedness Scale) asks 5 questions from a scale of 1-5 from strongly disagree to strongly agree with regards to connectedness and relationship satisfaction with each other. A higher score indicates higher child-parent connectedness. Both adolescents and parents will be asked these questions.

  12. Suicidal Thoughts [3 months]

    Adolescents who respond with anything besides "none" to the 9th question of the PHQ-9 will be asked to complete the brief CSSR-S scale. This scale asks two questions, have you (the participant) wished you (the participant) were dead or wished you (the participant) could go to sleep and not wake up? (yes/no) and have you (the participant) actually had any thoughts of killing yourself? (yes/no). Positive answers indicate suicidal thinking. These will be asked on an online survey. Those adolescents responding positively will complete a full CSSR-S interview.

  13. Suicidal Thoughts [6 months]

    Adolescents who respond with anything besides "none" to the 9th question of the PHQ-9 will be asked to complete the brief CSSR-S scale. This scale asks two questions, have you (the participant) wished you (the participant) were dead or wished you (the participant) could go to sleep and not wake up? (yes/no) and have you (the participant) actually had any thoughts of killing yourself? (yes/no). Positive answers indicate suicidal thinking. These will be asked on an online survey. Those adolescents responding positively will complete a full CSSR-S interview.

  14. Suicidal Thoughts [3 months]

    Adolescents who respond with positive answers to the brief CSSR-S will complete the full CSSR-S interview. The Columbia-Suicide Severity Rating Scale (C-SSRS) consists of interview questions regarding suicidal ideation, intensity of ideation, and suicidal behavior and will be asked with regards to preceeding 3 months. Researchers evaluate responses and categorize suicide severity based on these.

  15. Suicidal Thoughts [6 months]

    Adolescents who respond with positive answers to the brief CSSR-S will complete the full CSSR-S interview. The Columbia-Suicide Severity Rating Scale (C-SSRS) consists of interview questions regarding suicidal ideation, intensity of ideation, and suicidal behavior and will be asked with regards to preceeding 3 months. Researchers evaluate responses and categorize suicide severity based on these.

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Adolescent:
  • age 12 -18

  • prior or present history of depression per self-report and/or clinician diagnosis

  • scores between 5 or higher on PHQ-9 consistent with at least mild symptoms of depression

  • read and understand English

  • has an Android or iOS smartphone compatible with AWARE mobile application and access to a smartphone data plan

  • currently in United States

Parent/Guardian:
  • adolescent qualifies for study and assents to enroll

  • understands English

  • currently in United States

  • has a smartphone device that can download the intervention application

Healthcare Provider:
  • involved in providing mental health treatment (psychotherapy or antidepressant prescribing or making referrals) to adolescent participant - can be a primary care provider, therapist, subspecialist, psychiatrist
Exclusion Criteria:
Adolescent:
  • currently actively suicidal (have suicidal thoughts and plan with an intent to act on it)

  • plans to travel to countries belonging to the European Union (Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, The Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden), the United Kingdom (England, Scotland, Wales, and Northern Ireland), Norway, Iceland, or Lichtenstein in the next 6 months for more than 2 weeks at a time

Parent:
  • If their adolescent child is excluded
Healthcare Provider:
  • None

Contacts and Locations

Locations

Site City State Country Postal Code
1 Center for Adolescent and Young Adult Health Pittsburgh Pennsylvania United States 15213

Sponsors and Collaborators

  • Ana Radovic
  • NuRelm, Inc.
  • National Institute of Mental Health (NIMH)
  • University of Virginia

Investigators

  • Principal Investigator: Sam Shaaban, BSEE, MBA, NuRelm, Inc.
  • Principal Investigator: Ana Radovic, MD, MSc, University of Pittsburgh
  • Principal Investigator: Afsaneh Doryab, Ph.D. CS, University of Virginia

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ana Radovic, Assistant Professor of Pediatrics, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT05376358
Other Study ID Numbers:
  • STUDY21050120
  • R44MH122067
First Posted:
May 17, 2022
Last Update Posted:
Jul 13, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Ana Radovic, Assistant Professor of Pediatrics, University of Pittsburgh
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 13, 2022